CB2R PAM is an orally bioavailable positive allosteric modulator of the cannabinoid CB2 receptor. It potentiates agonist-stimulated G-protein activity in vitro and demonstrates efficacy in a murine neuropathic pain model, supporting research in analgesia and neuroinflammation.